JP2025507971A5 - - Google Patents
Info
- Publication number
- JP2025507971A5 JP2025507971A5 JP2024552478A JP2024552478A JP2025507971A5 JP 2025507971 A5 JP2025507971 A5 JP 2025507971A5 JP 2024552478 A JP2024552478 A JP 2024552478A JP 2024552478 A JP2024552478 A JP 2024552478A JP 2025507971 A5 JP2025507971 A5 JP 2025507971A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263316595P | 2022-03-04 | 2022-03-04 | |
| US63/316,595 | 2022-03-04 | ||
| PCT/CA2023/050280 WO2023164775A1 (en) | 2022-03-04 | 2023-03-03 | Radiolabeled compounds targetng the prostate-specific membrane antigen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025507971A JP2025507971A (ja) | 2025-03-21 |
| JP2025507971A5 true JP2025507971A5 (https=) | 2026-03-10 |
| JPWO2023164775A5 JPWO2023164775A5 (https=) | 2026-03-10 |
Family
ID=87882764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024552478A Pending JP2025507971A (ja) | 2022-03-04 | 2023-03-03 | 前立腺特異的膜抗原を標的とする放射性標識化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250186627A1 (https=) |
| EP (1) | EP4486756A1 (https=) |
| JP (1) | JP2025507971A (https=) |
| AU (1) | AU2023226956A1 (https=) |
| CA (1) | CA3244865A1 (https=) |
| WO (1) | WO2023164775A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020210909A1 (en) | 2019-04-17 | 2020-10-22 | Provincial Health Services Authority | Novel radiolabelled compounds for diagnosis or treatment of prostate-specific membrane antigen-expressing cancer |
| WO2025055943A1 (en) * | 2023-09-12 | 2025-03-20 | Shanghai Sinotau Biotech. Co., Ltd | Inhibitors of prostate specific membrane antigen and use thereof |
| CN121773094A (zh) * | 2023-09-12 | 2026-03-31 | 上海先通生物科技有限公司 | 前列腺特异性膜抗原的抑制剂和其用途 |
| WO2026002208A1 (zh) * | 2024-06-28 | 2026-01-02 | 思路迪生物医药(上海)有限公司 | 前列腺特异性膜抗原小分子抑制剂及其放射性核素配合物的制备及应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3544960A1 (en) * | 2016-11-23 | 2019-10-02 | Cancer Targeted Technology LLC | Albumin-binding psma inhibitors |
| US11629201B2 (en) * | 2017-05-24 | 2023-04-18 | ITM Isotope Technologies Munich SE | PSMA-binding agents and uses thereof |
| CN114401947B (zh) * | 2019-06-21 | 2024-11-29 | 省卫生服务机构 | 靶向前列腺特异性膜抗原的放射性标记化合物 |
| US11850291B2 (en) * | 2019-10-25 | 2023-12-26 | National Atomic Research Institute | PSMA targeted radiotherapy medicine and preparation method thereof |
-
2023
- 2023-03-03 CA CA3244865A patent/CA3244865A1/en active Pending
- 2023-03-03 EP EP23762646.0A patent/EP4486756A1/en active Pending
- 2023-03-03 WO PCT/CA2023/050280 patent/WO2023164775A1/en not_active Ceased
- 2023-03-03 AU AU2023226956A patent/AU2023226956A1/en active Pending
- 2023-03-03 US US18/842,681 patent/US20250186627A1/en active Pending
- 2023-03-03 JP JP2024552478A patent/JP2025507971A/ja active Pending